Pregnancy Testing Market on Track for $2.88 Billion by 2033, Driven by Rising Home Testing Adoption | Exclusive Data Like Latest M & A, Regulatory Approvals, FDA Approvals, Latest Investments, Reimbursements

The global pregnancy testing market reached US$ 1.63 billion in 2023, with a rise to US$ 1.72 billion in 2024, and is expected to reach US$ 2.88 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Pregnancy Testing Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/pregnancy-testing-market?rk

Latest M & A:

Major companies such as Abbott, Quidel, and Prestige Brands Holdings remain highly active in strategic partnerships and acquisitions to strengthen their market positions in both traditional and digital pregnancy testing kits.​

The sector is witnessing new entrants and regional manufacturers engaging in joint ventures and acquisition activity, particularly in developing markets.

Key Players:

Abbott Laboratories, BioMérieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., and Thermo Fisher Scientific Inc.

Key Development:

United States: Key Highlights:

The US at-home pregnancy testing market is expected to reach USD 1.169 billion by 2035, expanding at a CAGR of 5.2% from 2025, with notable growth driven by increasing consumer preference for convenience, privacy, and rapid results.​

Rapid technological advances, such as enhanced accuracy, smartphone integration, and intuitive interfaces, are driving higher adoption rates across the US.​

There is greater social acceptance of self-administered diagnostic tests, supported by regulatory approvals for over-the-counter sales and digital formats.​

Unplanned pregnancies and advances in digital tests have led to stronger demand, especially among younger and working women seeking reliable detection methods without clinical visits.​

Manufacturers are expanding product portfolios and distribution, partnering with major pharmacies and e-commerce platforms to improve accessibility and device availability.​

Japan: Key Highlights:

The Japan Fertility and Pregnancy Rapid Test Kits market is expected to grow at a CAGR of 6.07% from 2023 to 2033, reaching USD 195.16 million by 2033.​

Growth is strongly supported by government policies to improve reproductive health and encourage family planning, including financial incentives, work-life balance improvements, and broader access to diagnostic products.​

Advancements in at-home testing technologies such as digital and rapid tests are widely accepted for privacy and quick results, contributing to the shift toward non-clinical diagnostics.​

In 2025, Japan's fertility rate saw a slight increase, reflecting broader public adoption of pregnancy detection kits and supportive government initiatives.​

Market growth is also driven by partnerships with healthcare providers to extend distribution networks and address the population's need for easy-to-use, accurate diagnostics.

Growth Forecast Projected:

The Global Pregnancy Testing Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Regulatory Approvals & FDA Updates:

Regulatory frameworks worldwide have streamlined the approval processes for at-home pregnancy test kits, driving broader over-the-counter (OTC) access and accelerating adoption.​

The U.S. FDA and international equivalents have prioritized approval of digital and connected pregnancy diagnostics, resulting in more app-integrated and early-detection kits receiving market clearance.​

Obtainments of ISO, CE marking, and local authorizations are now standard for global market leaders and are reflected in recent product launches.

Research Process:

Both primary and secondary data sources have been used in the global Pregnancy Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=copy-of-pregnancy-testing-market?rk

Key Segments:

By Product Type: Pregnancy test kits (Strips/dipsticks and cards, Digital devices, Midstream kits, Cassettes), Fertility test kits (Line indicator kits, Digital devices).

By Test Type: hCG Blood, hCG Urine, FSH Urine, LH Urine.

By Distribution channel: Online Sales, Gynecology/ Fertility Clinics, Pharmacies/Drugstores, Hypermarkets, and Supermarkets.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Recent Investments:

Investments continue to flow into advanced diagnostics, especially digital home pregnancy tests and connected health platforms, with companies like Abbott expanding diagnostics manufacturing to meet regional demand.​

Government and payer spending on reproductive and maternal diagnostics in the U.S. exceeded USD 1.2 billion in 2023, with home test reimbursements gradually increasing under Medicaid and Medicare.​

Notable private equity and venture funding rounds are supporting both expanding manufacturing capacity and technology development.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pregnancy-testing-market?rk

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.